CAP2 Antikörper (AA 251-350)
Kurzübersicht für CAP2 Antikörper (AA 251-350) (ABIN732113)
Target
Alle CAP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    
- 
                                            
Bindungsspezifität
 - AA 251-350
 - 
                                            
Kreuzreaktivität
 - Human
 - 
                                            
Homologie
 - Mouse,Rat
 - 
                                            
Aufreinigung
 - Purified by Protein A.
 - 
                                            
Immunogen
 - KLH conjugated synthetic peptide derived from rat CAP2
 - 
                                            
Isotyp
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - 
                        ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Konzentration
 - 1 μg/μL
 - 
                                            
Buffer
 - 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
 - 
                                            
Haltbarkeit
 - 12 months
 
 - 
                                            
 - 
    
- 
                                            : "Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer."    in: Oncology reports, Vol. 36, Issue 4, pp. 1981-8, (2017)         (PubMed).        
 
 - 
                                            : "Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer."    in: Oncology reports, Vol. 36, Issue 4, pp. 1981-8, (2017)         (PubMed).        
 - 
    
- CAP2 (Adenylyl Cyclase Associated Protein 2 (CAP2))
 - 
                                            
Andere Bezeichnung
 - CAP2
 - 
                                            
Hintergrund
 - 
                        
Synonyms: Adenylyl cyclase associated protein 2, Adenylyl cyclase-associated protein 2, CAP 2, CAP adenylate cyclase associated protein 2, CAP adenylate cyclase-associated protein 2, CAP, adenylate cyclase associated protein, 2 yeast, cap2, CAP2_HUMAN.
Background: CAP2 is a identified by its similarity to the gene for human adenylyl cyclase-associated protein. The function of the protein encoded by this gene is unknown. However, the protein appears to be able to interact with adenylyl cyclase-associated protein and actin.
 - 
                                            
Gen-ID
 - 116653
 - 
                                            
UniProt
 - P52481
 
Target
 -